Robbins Arroyo LLP Is Investigating the Officers and Directors of Juniper Pharmaceuticals, Inc. on Behalf of Shareholders
27 October 2016 - 9:55AM
Business Wire
Shareholder rights law firm Robbins Arroyo LLP is investigating
whether certain officers and directors of Juniper Pharmaceuticals,
Inc. (NASDAQGS: JNP) violated federal securities laws by issuing
materially misleading information to the investing public. Juniper
Pharmaceuticals focuses on developing therapeutics that address
unmet medical needs in women's health.
Juniper Pharmaceuticals Announces Restatement of
Financials
On October 24, 2016, Juniper Pharmaceuticals announced in its
Form 8-K filed with the U.S. Securities and Exchange Commission
that it would have to restate its financial statements since 2013.
The company stated that the errors concerned revenue recognition
related to a supply agreement with an affiliate of Germany's Merck
KGaA. On this news, Juniper Pharmaceuticals stock fell 10% in early
morning trading on October 25, 2016.
View this press release on the law firm's Shareholder Rights
Blog:
www.robbinsarroyo.com/shareholders-rights-blog/juniper-pharmaceuticals-inc
Juniper Pharmaceuticals Shareholders Have Legal
Options
Concerned shareholders who would like more information about
their rights and potential remedies can contact attorney Darnell R.
Donahue at (800) 350-6003, DDonahue@robbinsarroyo.com, or via the
shareholder information form on the firm's website.
Robbins Arroyo LLP is a nationally recognized leader in
shareholder rights law. The firm represents individual and
institutional investors in shareholder derivative and securities
class action lawsuits, and has helped its clients realize more than
$1 billion of value for themselves and the companies in which they
have invested.
Attorney Advertising. Past results do not guarantee a similar
outcome.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20161026006973/en/
Robbins Arroyo LLPDarnell R. Donahue(619) 525-3990 or Toll Free
(800) 350-6003DDonahue@robbinsarroyo.comwww.robbinsarroyo.com
Juniper Pharmaceuticals, Inc. (NASDAQ:JNP)
Historical Stock Chart
From Apr 2024 to May 2024
Juniper Pharmaceuticals, Inc. (NASDAQ:JNP)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about Juniper Pharmaceuticals, Inc. (delisted) (NASDAQ): 0 recent articles
More Juniper Pharmaceuticals, Inc. (MM) News Articles